(Nasdaq: MIRM), a leading rare disease company, today announced completion of enrollment in the Phase 3 AZURE-1 study and completion of screening in the Phase 3 AZURE-4 study, both evaluating ...

LFT slightly high. There is no pain. No yellowing of the eyes. No weakness. So it is easy to brush it aside. But the liver rarely shouts in the beginning. It whispers.Liver Function Tests, or LFTs, ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs ...

The communities of Puntland, Somalia, have long engaged in environmentally harmful practices, including overgrazing, ...

Olam Agri Ghana has officially launched the 2026 edition of its flagship Healthy Baker Campaign, an annual initiative that has become one ...

At a Bloomington DSA forum, prosecutor candidates Erika Oliphant and Benjamin Arrington drew contrasts on marijuana ...